Should topical opioid analgesics be regarded as effective and safe when applied to chronic cutaneous lesions?

Journal of Pharmacy and Pharmacology

Volumn 63, Issue 6, 2011, Pages 747-756

  Farley, Peter ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

analgesia; cutaneous lesions; healing; morphine; topical opioid

Indexed keywords

CLONAZEPAM; DIAMORPHINE; DICLOFENAC; FENTANYL; LIDOCAINE; LOPERAMIDE; METHADONE; METRONIDAZOLE; MORPHINE; MORPHINE SULFATE; NARCOTIC ANALGESIC AGENT; OXYCODONE; PARACETAMOL; PETHIDINE; PLACEBO; PROXYMETACAINE; SULFADIAZINE; TRAMADOL; TRIAMCINOLONE;

ANALGESIA; APPLICATION SITE PAIN; CHRONIC DISEASE; DISEASE ASSOCIATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG INTOXICATION; DRUG RELEASE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EYE PAIN; GASTROINTESTINAL SYMPTOM; HUMAN; MOUTH PAIN; NONHUMAN; PAIN; PRURITUS; REVIEW; SKIN BURNING SENSATION; SKIN DEFECT; SYSTEMIC SCLEROSIS; WOUND HEALING;

ADMINISTRATION, CUTANEOUS; ANALGESIA; ANALGESICS, OPIOID; HUMANS; MORPHINE; PAIN; SKIN; TREATMENT OUTCOME; WOUND HEALING; WOUNDS AND INJURIES;

EID: 79956206894     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01252.x     Document Type: Review

References (82)

1. Hanks G,. Opioid responsive and opioid non-responsive pain in cancer. Br Med Bull 1991; 47: 718-731.
2. Grey J, et al,. ABC of wound healing: venous and arterial leg ulcers. Br Med J 2006; 332: 347-350. (Pubitemid 43253753)
3. Heinen MM, et al,. Ulcer-related problems and health care needs in patients with venous leg ulceration: a descriptive, cross-sectional study. Int J Nurs Stud 2006; 44: 1296-1303.
4. Heinen MM, et al,. Venous leg ulcer patients: a review of the literature on lifestyle and pain-related interventions. J Clin Nurs 2004; 13: 355-366. (Pubitemid 38470872)
5. de Laat EH, et al,. Pressure ulcers: diagnostics and interventions aimed at wound-related complaints: a review of the literature. J Clin Nurs 2005; 14: 464-472. (Pubitemid 40515957)
6. Herber O, et al,. A systematic review on the impact of leg ulceration on patients' quality of life. Health Qual Life Outcomes 2007; 5: 44.
7. Buxton P,. ABC of dermatology. Leg ulcers. Br Med J 1987; 295: 1542-1545.
8. Roden A, Sturman E,. Assessment and management of patients with wound-related pain. Nurs Stand 2009; 23: 53-54, 56, 58 passim.
9. Benbow M,. Understanding patients' wound pain is crucial. Br J Nurs 2009; 18: S3.
10. Szor JK, Bourguignon C,. Description of pressure ulcer pain at rest and at dressing change. J Wound Ostomy Continence Nurs 1999; 26: 115-120.
11. Price PE, et al,. Dressing-related pain in patients with chronic wounds: an international patient perspective. Int Wound J 2008; 5: 159-171. (Pubitemid 351731674)
12. Ruckley CV,. Caring for patients with chronic leg ulcer. Br Med J 1998; 316: 407-408.
13. ABC of wound healing: venous and arterial leg ulcers. Student BMJ 2006; 14: 133-176.
14. Chase K, et al,. A forever healing: the lived experiences of venous ulcer disease. J Vasc Nurs 1997; 15: 73-78.
15. Nelzen O, et al,. Long-term prognosis for patients with chronic leg ulcers: a prospective cohort study. Eur J Vasc Endovasc Surg 1997; 13: 500-508. (Pubitemid 27249887)
16. Thompson DF, Pierce DR,. Local analgesia with opioid drugs. Ann Pharmacother 1995; 29: 189-190.
17. Stein C, Lang LJ,. Peripheral mechanisms of opioid analgesia. Curr Opin Pharmacol 2009; 9: 3-8.
18. Rittner HL, et al,. Pain and the immune system. Br J Anaesth 2008; 101: 40-44. (Pubitemid 351881900)
19. Machelska H, et al,. Different mechanisms of intrinsic pain inhibition in early and late inflammation. J Neuroimmunol 2003; 141: 30-39.
20. Jorgensen B, et al,. Pain and quality of life for patients with venous leg ulcers: proof of concept of the efficacy of Biatain-Ibu, a new pain reducing wound dressing. Wound Repair Regen 2006; 14: 233-239. (Pubitemid 43979251)
21. Briggs M, Nelson EA,. Topical agents or dressings for pain in venous leg ulcers. Cochrane Database Syst Rev 2010; 4: CD001177.
22. El-Ghoneimi A, et al,. Intravesical morphine analgesia is not effective after bladder surgery in children: results of a randomied double-blind study. J Urol 2002; 168: 694-697. (Pubitemid 34793340)
23. Likar R, et al,. Dose-dependency of intra-articular morphine analgesia. Br J Anaesth 1999; 83: 241-244. (Pubitemid 29361133)
24. Rosseland LA, et al,. Effective pain relief from intra-articular saline with or without morphine 2 mg in patients with moderate-to-severe pain after knee arthroscopy: a randomized, double-blind controlled clinical study. Acta Anaesthesiol Scand 2003; 47: 732-738. (Pubitemid 36760705)
25. Fu P, et al,. Efficacy of intra-articular cocktail analgesic injection in total knee arthroplasty-a randomized controlled trial. Knee 2009; 16: 280-284.
26. Gupta A, et al,. A systematic review of the peripheral analgesic effects of intraarticular morphine. Anesth Analg 2001; 93: 761-770. (Pubitemid 32783308)
27. Duckett JW, et al,. Intravesical morphine analgesia after bladder surgery. J Urol 1997; 157: 1407-1409. (Pubitemid 27130835)
28. Rosseland LA,. No evidence for analgesic effect of intra-articular morphine after knee arthroscopy: a qualitative systematic review. Reg Anesth Pain Med 2005; 30: 83-98. (Pubitemid 40187276)
29. Westerling D, et al,. Transdermal administration of morphine to healthy subjects. Br J Clin Pharmacol 1994; 37: 571-576. (Pubitemid 24197151)
30. Paice JA, et al,. Morphine bioavailability from a topical gel formulation in volunteers. J Pain Symptom Manage 2008; 35: 314-320. (Pubitemid 351273535)
31. Murdan S,. A review of pluronic lecithin organogel as a topical and trandermal drug delivery system. Hosp Pharmacist 2005; 12: 267-270. (Pubitemid 41059009)
32. Wang J-J, et al,. Ester prodrugs of morphine improve transdermal drug delivery: a mechanistic study. J Pharm Pharmacol 2007; 59: 917-925. (Pubitemid 47051071)
33. Ribeiro MDC, et al,. The bioavailability of morphine applied topically to cutaneous ulcers. J Pain Symptom Manage 2004; 27: 434-439. (Pubitemid 38569649)
34. Long TD, et al,. Morphine-infused silver sulfadiazine (MISS) cream for burn analgesia: a pilot study. J Burn Care Rehabil 2001; 22: 118-123. (Pubitemid 32285122)
35. Gallagher RE, et al,. Analgesic effects of topical methadone-a report of four cases. Clin J Pain 2005; 21: 190-192. (Pubitemid 40280235)
36. van Ingen I, et al,. Topical opioids for painful ulcers in systemic sclerosis. Ann Rheum Dis 2008; 67: 427. (Pubitemid 351281284)
37. Cerchietti LCA, et al,. Potential utility of the peripheral analgesic properties of morphine in stomatitis-related pain: a pilot study. Pain 2003; 105: 265-273. (Pubitemid 37162496)
38. Peyman GA, et al,. Effects of morphine on corneal sensitivity and epithelial wound healing: implications for topical ophthalmic analgesia. Br J Ophthalmol 1994; 78: 138-141. (Pubitemid 24053141)
39. Stiles J, et al,. Effect of topical administration of 1% morphine sulfate solution on signs of pain and corneal wound healing in dogs. Am J Vet Res 2003; 64: 813-818. (Pubitemid 36826897)
40. Zagon IS, et al,. Re-epithelialization of the rabbit cornea is regulated by opioid growth factor. Brain Res 1998; 803: 61-68. (Pubitemid 28392130)
41. Zagon IS, et al,. Re-epithelialization of the rat cornea is accelerated by blockade of opioid receptors. Brain Res 1998; 798: 254-260. (Pubitemid 28342043)
42. Zagon IS, et al,. Reepithelialization of the human cornea is regulated by endogenous opioids. Invest Ophthalmol Vis Sci 2000; 41: 73-81. (Pubitemid 30036551)
43. Zagon IS, et al,. Naltrexone accelerates healing without compromise of adhesion complexes in normal and diabetic corneal epithelium. Brain Res Bull 2007; 72: 18-24. (Pubitemid 46227741)
44. Poonawala T, et al,. Opioids heal ischemic wounds in the rat. Wound Repair Regen 2005; 13: 165-174. (Pubitemid 40489866)
45. Rook JM, et al,. Temporal effects of topical morphine application on cutaneous wound healing. Anaesthesiology 2008; 109: 130-136.
46. Rook JM, et al,. Morphine-induced early delays in wound closure: involvement of sensory neuropeptides and modification of neurokinin receptor expression. Biochem Pharmacol 2009; 77: 1747-1755.
47. Gupta K, et al,. Abnormal angiogenesis, neurogenesis and lymphangiogenesis in the skin underlies delayed wound healing in the sickle mouse: acceleration of healing by topical opioids. Blood 2005; 106: Abstract 3177.
48. Clark JD, et al,. Morphine reduces local cytokine expression and neutrophil infiltration after incision. Mol Pain 2007; 3: 28.
49. Lam CF, et al,. Prolonged use of high-dose morphine impairs angiogenesis and mobilization of endothelial progenitor cells in mice. Anesth Analg 2008; 107: 686-692.
50. Wolf NB, et al,. Influences of opioids and nanoparticles on in vitro wound healing models. Eur J Pharm Biopharm 2009; 73: 34-42.
51. Kuchler S, et al,. 3D-wound healing model: influence of morphine and solid lipid nanoparticles. J Biotechnol 2010; 148: 24-30.
52. Martin JL, et al,. Chronic morphine administration delays wound healing by inhibiting immune cell recruitment to the wound site. Am J Pathol 2010; 176: 786-799.
53. Jacobsen J,. Topical opioids for pain #185. J Palliat Med 2009; 12: 380-381.
54. Back IN, Finlay I,. Analgesic effect of topical opioids on painful skin ulcers. J Pain Symptom Manage 1995; 10: 493.
55. Krajnik M, Zylicz Z,. Topical morphine for cutaneous cancer pain. Palliat Med 1997; 11: 325. (Pubitemid 27373038)
56. Krajnik M, et al,. Potential uses of topical opioids in palliative care-report of 6 cases. Pain 1999; 80: 121-125. (Pubitemid 29151696)
57. Twillman RK, et al,. Treatment of painful skin ulcers with topical opioids. J Pain Symptom Manage 1999; 17: 288-292. (Pubitemid 29159971)
58. Flock P, et al,. Diamorphine-metronidazole gel effective for treatment of painful infected leg ulcers. J Pain Symptom Manage 2000; 20: 396-397.
59. Ballas SK,. Treatment of painful sickle cell leg ulcers with topical opioids. Blood 2002; 99: 1096. (Pubitemid 34525580)
60. Watterson G, et al,. Peripheral opioids in inflammatory pain. Arch Dis Child 2004; 89: 697-681.
61. Ashfield T,. The use of topical opioids to relieve pressure ulcer pain. Nurs Stand 2005; 19: 90-92.
62. Porzio G, et al,. Topical morphine in the treatment of painful ulcers. J Pain Symptom Manage 2005; 30: 304-305. (Pubitemid 41527115)
63. Tran Q, Fancher T,. Achieving analgesia for painful ulcers using topically applied morphine gel. J Support Oncol 2007; 5: 289-293. (Pubitemid 46995364)
64. Barker S,. Analgesic effect of locally applied morphine to pyoderma gangrenosum. Clin Exp Dermatol 2009; 34: 91-92.
65. Flock P,. Pilot study to determine the effectiveness of diamorphine gel to control pressure ulcer pain. J Pain Symptom Manage 2003; 25: 547-554. (Pubitemid 36629278)
66. Zeppetella G, et al,. Analgesic efficacy of morphine applied topically to painful ulcers. J Pain Symptom Manage 2003; 25: 555-558. (Pubitemid 36629279)
67. Zeppetella G, Ribeiro MD,. Morphine in intrasite gel applied topically to painful ulcers. J Pain Symptom Manage 2005; 29: 118-119. (Pubitemid 40279048)
68. Abbas S,. Diamorphine-intrasite dressings for pressure sores in palliative care. Eur J Intern Med 2003; 14 (Suppl. 1): S95.
69. Abbas SQ,. Diamorphine-intrasite dressings for painful pressure ulcers. J Pain Symptom Manage 2004; 28: 532-534. (Pubitemid 39626095)
70. Nozaki-Taguchi N, Yaksh TL,. Characterization of the antihyperalgesic action of a novel peripheral mu-opioid receptor agonist-loperamide. Anesthesiology 1999; 90: 225-234.
71. Nevius J, et al,. Efficacy evaluation of ADL 2-1294 (loperamide hydrochloride ophthalmic solution 0.025%) vs. placebo for short term pain management. Invest Ophthalmol Vis Sci 2000; 41 (Suppl. 4917): S925.
72. Nozaki-Taguchi N, et al,. Potential utility of peripherally applied loperamide in oral chronic graft-versus-host disease related pain. Jpn J Clin Oncol 2008; 38: 857-860.
73. Ray SB,. Loperamide: a potential topical analgesic for the treatment of burn pain. J Burn Care Res 2006; 27: 121-122. (Pubitemid 43970357)
74. Vernassiere C, et al,. Study to determine the efficacy of topical morphine on painful chronic skin ulcers. J Wound Care 2005; 14: 289-293.
75. Jansen M, et al,. Lack of analgesic effect from topical morphine in painful arterial leg ulcers. Br J Clin Pharmacol 2005; 60: 674-674.
76. Skiveren J, et al,. Morphine gel 0.3% does not relieve pain during topical photodynamic therapy: a randomized, double-blind, placebo controlled study. Acta Derm Venereol 2006; 86: 409-411. (Pubitemid 44450095)
77. Welling A,. A randomised controlled trial to test the analgesic efficacy of topical morphine on minor superficial and partial thickness burns in accident and emergency departments. Emerg Med J 2007; 24: 408-412.
78. Oeltjenbruns J, Schafer M,. Peripheral opioid analgesia: clinical applications. Curr Pain Headache Rep 2005; 9: 36-44. (Pubitemid 40277779)
79. Wenk HN, et al,. Morphine directly inhibits nociceptors in inflamed skin. J Neurophysiol 2006; 95: 2083-2097.
80. Stein C, et al,. Peripheral mechanisms of pain and analgesia. Brain Res Rev 2009; 60: 90-113.
81. Lee R,. Topical morphine for painful skin ulcers in palliative care-a treatment guideline. 2009. Richard W K Lee Pharmacist for East Lancashire Medicines Management Board representing East Lancashire Hospitals NHS Trust.
82. World Health Organization. Alternatives to the oral delivery of opioids. Cancer Pain Release 2003.